However, perhaps the reason most people want to see a SpaceX IPO is because itâs one of the many brainchildren of Tesla (TSLA) CEO Elon Musk, who has consistently made huge returns for stock investors since the late 1990s.
A good way to think about the STP process is that it is a analytical approach that helps the firm make important âwhereâ (target market selection) and âhowâ (product positioning) to compete marketing strategy decisions.
EP-100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYPTM) platform technology, is a targeted membrane-disrupting peptide (tMDP) designed to seek and destroy cancer cells that over-express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.